Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Clinical trial NCT04910854 · UNKNOWN
Trial details
- NCT number
- NCT04910854
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2022-03-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.